256 related articles for article (PubMed ID: 27798244)
1. The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.
Cardinal H; Dieudé M; Hébert MJ
J Am Soc Nephrol; 2017 Feb; 28(2):400-406. PubMed ID: 27798244
[TBL] [Abstract][Full Text] [Related]
2. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
Dragun D; Catar R; Philippe A
Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?
Delville M; Charreau B; Rabant M; Legendre C; Anglicheau D
Hum Immunol; 2016 Nov; 77(11):1055-1062. PubMed ID: 27237040
[TBL] [Abstract][Full Text] [Related]
4. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
[TBL] [Abstract][Full Text] [Related]
5. The importance of non-HLA antibodies in transplantation.
Zhang Q; Reed EF
Nat Rev Nephrol; 2016 Aug; 12(8):484-95. PubMed ID: 27345243
[TBL] [Abstract][Full Text] [Related]
6. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell antibodies associated with novel targets and increased rejection.
Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM
J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426
[TBL] [Abstract][Full Text] [Related]
8. Isolated De Novo Antiendothelial Cell Antibodies and Kidney Transplant Rejection.
Sánchez-Zapardiel E; Mancebo E; Díaz-Ordoñez M; de Jorge-Huerta L; Ruiz-Martínez L; Serrano A; Castro-Panete MJ; Utrero-Rico A; de Andrés A; Morales JM; Domínguez-Rodríguez S; Paz-Artal E
Am J Kidney Dis; 2016 Dec; 68(6):933-943. PubMed ID: 27599627
[TBL] [Abstract][Full Text] [Related]
9. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
10. Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation.
Toresan R; Manfro RC; Proença MC; Veronese FJ; Salim PH; da Silva DM; Ribeiro AR; Edelweiss MI; Pegas KL; Jobim LF
Transplant Proc; 2008 Apr; 40(3):718-9. PubMed ID: 18454996
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation.
Freischlag K; Pearl MH; Chambers ET
Clin Transpl; 2016; 32():31-43. PubMed ID: 28564521
[TBL] [Abstract][Full Text] [Related]
12. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies.
Guo X; Hu J; Luo W; Luo Q; Guo J; Tian F; Ming Y; Zou Y
J Immunol Res; 2017; 2017():8679841. PubMed ID: 28265584
[TBL] [Abstract][Full Text] [Related]
14. Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation.
Gerlach UA; Lachmann N; Ranucci G; Sawitzki B; Schoenemann C; Pratschke J; Dragun D; Pascher A
Transplantation; 2017 Jan; 101(1):141-149. PubMed ID: 27495766
[TBL] [Abstract][Full Text] [Related]
15. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
16. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.
Lee PC; Terasaki PI; Takemoto SK; Lee PH; Hung CJ; Chen YL; Tsai A; Lei HY
Transplantation; 2002 Oct; 74(8):1192-4. PubMed ID: 12438971
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
[TBL] [Abstract][Full Text] [Related]
18. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy.
Martin L; Guignier F; Mousson C; Rageot D; Justrabo E; Rifle G
Transplantation; 2003 Jul; 76(2):395-400. PubMed ID: 12883199
[TBL] [Abstract][Full Text] [Related]
19. Monitoring anti-HLA Class I IgG antibodies in renal transplant recipients.
Aragão E; Moura LA; Pacheco-Silva A
Transplant Proc; 2004 May; 36(4):836-7. PubMed ID: 15194287
[TBL] [Abstract][Full Text] [Related]
20. Utility of HLA Antibody Testing in Kidney Transplantation.
Konvalinka A; Tinckam K
J Am Soc Nephrol; 2015 Jul; 26(7):1489-502. PubMed ID: 25804279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
